Company Filing History:
1 out of 1,736 
1 out of 470 Years Active: 2018
Title: Innovations in Canine Lymphoma Diagnosis by Joseph Legutki
Introduction
Joseph Legutki is an accomplished inventor based in Tempe, Arizona. He has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and characterization of canine lymphoma. His innovative approach utilizes advanced immunosignature techniques to improve diagnostic accuracy and treatment evaluation.
Latest Patents
Joseph Legutki holds a patent for "Immunosignature based diagnosis and characterization of canine lymphoma." This patent outlines methods for diagnosing and characterizing lymphoma, as well as evaluating the disease-free interval following treatment. The process involves utilizing patient antibodies bound to peptide microarrays, which are compared to an immunosignature characteristic of either a lymphoma state or a non-lymphoma state. Additionally, the characterization includes subtyping of lymphoma by identifying immunosignature characteristics of B-cell or T-cell lymphoma.
Career Highlights
Throughout his career, Joseph has worked with notable institutions such as Arizona State University and Colorado State University Research Foundation. His work has focused on enhancing the understanding and treatment of canine lymphoma, contributing to advancements in veterinary diagnostics.
Collaborations
Joseph Legutki has collaborated with esteemed colleagues, including Stephen Albert Johnston and Douglas Thamm. Their combined expertise has furthered research in the field of veterinary oncology.
Conclusion
Joseph Legutki's innovative work in the diagnosis of canine lymphoma represents a significant advancement in veterinary medicine. His contributions are paving the way for improved diagnostic methods and better outcomes for canine patients.